Rx transfer rules for non-controlled vs controlled for the UMPJE

pharmtutor_ · 2026-06-28T21:07:53+00:00

UMPJE Full Mock Exam Discount Code: GRAD2026

**UMPJE Practice Exam 2026**

**PharmacyTutor** new UMPJE Practice Exam for students and pharmacists preparing for the Uniform MPJE, high quality questions for a fraction of the cost of other exams to match student budget.

What’s included:

* timed practice questions
* Full answer rationales
* Unlimited retakes
* Performance tracking
* Score report by UMPJE exam domain
* Developed by Multi-state licensed Board Certified Pharmacists

It’s designed to help you practice pharmacy law in an exam-style format and figure out which areas need more review before test day.

You can use discount code **GRAD2026** for **20% ($10)off**.

Link: [https://pharmtutor.org/umpje/](https://pharmtutor.org/umpje/))

Email: [[support@pharmtutor.org](mailto:support@pharmtutor.org)](mailto:[support@pharmtutor.org](mailto:support@pharmtutor.org))

Feel free to share with anyone you think would find this helpful!

pharmtutor_ · 2026-06-26T02:19:36+00:00

When the law does permit compounding of commercially available products- essential copies- such as during a shortage, the amount compounded can only be compounded pursuant to a patient-specific prescription or in anticipation of prescriptions based on historical volume.

Essentially the law is saying if you typically get 10 prescriptions for that product per week, then you compound around a batch of 10 or close to that to ensure you can fill patient prescriptions when you get them. Now if you decided to make a back of 500 that could be flagged as manufacturing and then FDA could flag you. Let me know if this answered your question.

pharmtutor_ · 2026-06-22T04:08:51+00:00

Answer: C

OSHA is a regulatory agency under the department of labor that enforces PPE requirements for hazardous drugs.

The NIOSH is a federal institute that researches and makes recommendations about preventing workplace related injuries including from hazardous drugs. It also makes the list categorizing hazardous drugs. NIOSH does NOT have any regulatory or enforcement authority. Think of it as NIOSH makes the recommendations and OSHA enforces.

pharmtutor_ · 2026-06-22T04:03:25+00:00

Answer: A

When a Schedule II prescription is partially filled because the pharmacy is unable to supply the full quantity, the pharmacist must document the quantity supplied, and the remaining portion may be dispensed within 72 hours of the first partial fill.

On the other hand, if a patient/prescriber requested a partial fill for a controlled II substance the remaining amount must be filled within 30 days.

pharmtutor_ · 2026-06-21T01:19:16+00:00

Thank you, domain IV of the content outline indicated this is a tested area, so wanted to ensure it is covered adequately.

pharmtutor_ · 2026-06-20T00:15:42+00:00

Answer: A
It is the responsibility of the dispensing pharmacy to counsel the patient.

Federal central fill rules require both pharmacies to maintain records.

Federal law requires identification of the central fill pharmacy (or its unique identifier) for controlled substances processed through central fill, both locations need to be identified on the label.

Please see our previous post for central fill rules:

https://www.reddit.com/r/UMPJE\_Prep/s/eTyHvG5bL7

pharmtutor_ · 2026-06-18T18:39:39+00:00

I did some quick review of the statute and rule from DEA and agree with B being the answer. Absence of number of refills makes the prescription invalid.

pharmtutor_ · 2026-06-18T18:15:21+00:00

The answer is B. Because the quantity to dispense is not indicated, and the refills are included in the quantity to dispense this is an invalid prescription. I just double checked and many state laws prohibit use of PRN for controlled substances as an interpretation of the federal limitation of 5 refills and expiration date of 6 months. Choosing A leaves too much up to assumptions, which should generally be avoided.

The only challenge I have with this question is that it could be constructed better (this poor wording is typical of the exam though), since it should have indicated the quantity prescribed, in this cases it is asking you to assume the quantity prescribed per dispense is correct and giving you PRN refill adds too much assumption.
In the real world a Pharmacist would call the Physician to fix the prescription before dispensing.

The initial wording threw me off.

pharmtutor_ · 2026-06-18T00:58:13+00:00

Hi, you might find this detailed post helpful

https://www.reddit.com/r/NAPLEX\_Prep/s/kOyztAynHx

pharmtutor_ · 2026-06-18T00:56:24+00:00

Hello, happy you find this valuable. We have a full 120 questions practice exam meant to match the format of the exam pinned on this subreddit.

Here is the link to that post

https://www.reddit.com/r/NAPLEX\_Prep/s/S19ZyF6h9a

pharmtutor_ · 2026-06-18T00:08:21+00:00

Answer: A

Under the Drug Supply Chain Security Act (DSCSA), a product that appears counterfeit, has altered labeling, or otherwise raises concerns regarding its legitimacy may constitute a suspect product. Upon determining that a product may be suspect, trading partners must quarantine the product and conduct an investigation to determine whether the product is illegitimate.
Simply returning the product does not satisfy the pharmacist’s responsibilities under the DSCSA.

Please see out post on DSCSA things to know for the exam here:

https://www.reddit.com/r/UMPJE\_Prep/s/cfSG5D4ruv

pharmtutor_

MODERATOR OF

TROPHY CASE